An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain

por Ruiz-Aragón, Jesús, Márquez-Peláez, Sergio
Publicado 2023

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain

por Ruiz-Aragón, Jesús, Márquez-Peláez, Sergio, Gani, Ray, Alvarez, Piedad, Guerrero-Luduena, Richard
Publicado 2022

An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population

por Fochesato, Anna, Sottile, Sara, Pugliese, Andrea, Márquez-Peláez, Sergio, Toro-Diaz, Hector, Gani, Ray, Alvarez, Piedad, Ruiz-Aragón, Jesús
Publicado 2022

An alternative model in the provision of CPAP in sleep apnea: a comparative cost analysis

por Gonzalez-Vergara, Demetrio, Marquez-Pelaez, Sergio, Alfonso-Arias, Jose David, Perez-Ramos, Julia, Rojas-Box, Jose Luis, Aumesquet-Nosea, Manuel
Publicado 2021

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion

por Postma, Maarten, Fisman, David, Giglio, Norberto, Márquez-Peláez, Sergio, Nguyen, Van Hung, Pugliese, Andrea, Ruiz-Aragón, Jesús, Urueña, Analia, Mould-Quevedo, Joaquin
Publicado 2023

1166. The Cost-Effectiveness Evidence of Enhanced Influenza Vaccines in Adults ≥65 Years of Age: A Literature Review and Decision-Making Implications

por Giglio, David FismanNorberto, Márquez-Peláez, Sergio, Nguyen, Van, Postma, Maarten, Pugliese, Andrea, Ruiz-Aragón, Jesús, urueña, Analia, Mould-Quevedo, Joaquin F
Publicado 2023